NextPharma Technologies’ development facility in Braine l’Alleud, Belgium has received positive early feedback following an inspection by the country’s drug watchdog, the AFMPS.
US group Cambridge Major Laboratories (CML) will begin transferring API production to its 125,000 sq ft manufacturing plant in Germantown, Wisconsin at the end of next month.
Clinical trials in the developing world meet the same standards as those in Europe and the US and are vital for accelerating drug development says the Association of Clinical Research Organisations (ACRO).
SAFC Supply Solutions has launched a new materials sourcing offering, designed to meet the medical diagnostics sector’s demand for raw materials that are compliant with international regulatory standards.
Italian contract research organisation (CRO) Pierrel has acquired Encorium’s US clinical trial operations in a $2.7m (€1.9m) deal that could provide a much needed lifeline for the troubled group.
Austria’s Borealis has brought its Bormed LE6609-PH BFS grade plastic back to market in a move that, it claims, will allow converters to speed up their production cycles by reducing autoclave residence time.
India’s Central Drug Standard Control Organisation (CDSCO) wants CROs and trial sponsors to justify and document the increasingly large quantities of drugs and APIs they import for clinical trials.
Australian group Amcor has confirmed that talks about a takeover of Alcan’s pharmaceutical packaging business are still ongoing but says that no binding agreement has yet been reached.
Rumours suggest that US drug giant Pfizer is considering a bid for Turkish generics group Abdi Ibrahim as part of its strategy of expanding in emerging markets.
The US consumer healthcare products division of GlaxoSmithKline (GSK) has hired Informance International to implement overall equipment effectiveness (OEE) analysis at its facilities in Clifton, New Jersey and Aiken, South Carolina.
French biopharmaceutical group LFB has contracted Lonza’s biopharmaceuticals division to make trial supplies of its candidated monoclonal anti-RhD antibody.
SAFC’s bioscience unit and Sartorius Stedim Biotech (SSB) have teamed up to create a suite of fluid management solutions that they hope will prove irresistible to the booming biomanufacturing sector.
Andrew Baker, the chairman and CEO of Life Sciences Research, an East Millstone, New Jersey, contract research organization, has obtained "a definitive agreement" to acquire the firm for $8.50 per share in cash.
UK CRO Chiltern International announced positive financial results for the year ending March 2009, possibly suggesting a bounce for a sector that has been hit by project cancellations.
US drugmaker Oscient Pharmaceuticals has filed for chapter 11 bankruptcy and will sell its bronchitis therapy Factive (gemifloxacin mesylate) to North Carolina-based Cornerstone Therapeutics for $5m (€3.5m).
Gerresheimer has cut its forecast for 2009 after a poor second quarter that saw gains made in drug packaging pegged back by falling demand from the cosmetics industry.
The US National Cancer Institute (NCI) will provide specialist trial group Cancer Research for the Ozarks (CRO) with a $4.2m grant to support its clinical programme.
US software company Velos hopes its new “software as a service” (SaaS) internet offering will attract CROs and Pharma firms seeking low-cost trial management solutions.
The Oxford, UK, biomarker laboratory facilities of India’s Veeda CR have been taken over by Icon Development Solutions, in a deal which both consolidates existing customer relationships for the buyer and opens up new product areas to focus on.
Mallinckrodt Pharmaceuticals has recalled one batch of its sodium chromate Cr-51 diagnostic agent after FDA post-marketing tests revealed that some of the products were “subpotent.”
Swiss firm Roche has begun making cuts at recent $46.8bn biotech acquisition Genentech, in the first stage of a widely anticipated integration programme.
Indian generics firm Ranbaxy voluntarily withdrew one batch of its acne drug isotretinoin from US shelves late last week after FDA analysis revealed out of spec dissolution test results.
US CRO PPD has laid off around 80 people at its HQ in Wilmington, North Carolina and may cut another 200 jobs from its North American workforce, according to local media reports.
There will be no major changes in the short term after the “surprise” decision by the EC to drop the directive about some excipients having to comply with GMP, according to a freelance consultant.
US contract manufacturer West Pharmaceutical Services has purchased French device firm Plastef Investissements’ drug delivery business, adding the eris safety syringe system to its offering.
in-PharmaTechnologist presents its latest roundup of appointments in the pharmaceutical sector, including movements at UCB Pharma Canada and a resignation at GeoVax.
South-Africa based ACRO is aiming at building partnerships across its home continent, according to its MD who told Outsourcing-Pharma of its ambition to have more local people performing research.
US contract services firm Norwich Pharmaceuticals has teamed up with Emerson Resources in a partnership that both claim will help drug industry partners bring products to market.
US contract research organisation (CRO) QPS has been called in by the Taiwanese Development Center for Biotechnology (DCB) to provide support services for biotech firms operating in the region.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at Covance, Sundia MediTech and Cardinal.
Cozzoli believes its new powder filling line, which is capable of depositing varying doses of antibiotics into differing sizes of vials, can help companies reduce the risk of contamination.
NXP and Siemens have collaborated to create a RFID system capable of bulk reading hundreds of labels, which they believe could improve efficiencies across the pharma supply chain.
Singapore-based Industrial cleanroom and containment specialist Esco Micro has rolled out the latest generation of its Pharmacon Downflow booths for pharmaceutical sampling, grinding, dispensing and filling operations.
The number of CROs operating in the United Arab Emirates (UAE) is set to rise, according to an expert on the region, as companies are attracted by the cost effectiveness and presence of big pharma.
India and China share many similarities as outsourcing locations but there are also significant differences that are important to understand before making a commitment, according to a report.
Novartis and Jubilant Organosys are among several companies forced to recall generic drugs after manufacturing operations at their shared CMO, India’s MJ Biopharm, were found to be in breach of GMP guidelines.
Ultrasonic particle engineering specialist Prosonix has been accredited under the ISO 9001:2008 quality scheme, after an inspection by the UK unit of independent auditing group SGS.